(Q48278030)

10 February 2018

title

Seeing what Alzheimer saw. (English)

1 reference

10 February 2018

0 references

3

1 reference

10 February 2018

Mony J de Leon

object named as

Mony J de Leon

series ordinal

1

0 references

author name string

Lisa Mosconi

series ordinal

2

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 February 2007

1 reference

10 February 2018

published in

Nature Medicine

1 reference

10 February 2018

volume

13

1 reference

10 February 2018

issue

2

1 reference

10 February 2018

page(s)

129-131

1 reference

10 February 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNM0207-129

Phases of A beta-deposition in the human brain and its relevance for the development of AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0207-129

PET of brain amyloid and tau in mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0207-129

7 January 2021

Neuropathological stageing of Alzheimer-related changes

1 reference

https://api.crossref.org/works/10.1038%2FNM0207-129

7 January 2021

https://api.crossref.org/works/10.1038%2FNM0207-129

1 reference

7 January 2021

Neuropathology of older persons without cognitive impairment from two community-based studies

1 reference

https://api.crossref.org/works/10.1038%2FNM0207-129

7 January 2021

Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET).

1 reference

https://api.crossref.org/works/10.1038%2FNM0207-129

7 January 2021

Hippocampal hypometabolism predicts cognitive decline from normal aging

1 reference

https://api.crossref.org/works/10.1038%2FNM0207-129

7 January 2021

Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging

1 reference

https://api.crossref.org/works/10.1038%2FNM0207-129

7 January 2021

Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.

1 reference

https://api.crossref.org/works/10.1038%2FNM0207-129

7 January 2021

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

1 reference

https://api.crossref.org/works/10.1038%2FNM0207-129

7 January 2021

Binding Characteristics of Radiofluorinated 6-Dialkylamino-2-Naphthylethylidene Derivatives as Positron Emission Tomography Imaging Probes for β-Amyloid Plaques in Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1038%2FNM0207-129

7 January 2021

Cognitive measures predict pathologic Alzheimer disease

1 reference

https://api.crossref.org/works/10.1038%2FNM0207-129

7 January 2021

Distribution volume ratios without blood sampling from graphical analysis of PET data

1 reference

https://api.crossref.org/works/10.1038%2FNM0207-129

7 January 2021

Identifiers

DOI

10.1038/NM0207-129

1 reference

10 February 2018

1 reference

10 February 2018